--- title: "U.S. stock night market opening fluctuations: Diginext fell 7.58% in the night market; Onfolio fell 4.63% in the night market" type: "News" locale: "en" url: "https://longbridge.com/en/news/296037186.md" description: "Diginext fell 7.58% in the night session; Onfolio fell 4.63% in the night session; Skye Bioscience rose 32.92% in the night session; SurgePays rose 15.78% in the night session; YXT.COM rose 15.41% in the night session" datetime: "2026-08-17T00:22:30.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296037186.md) - [en](https://longbridge.com/en/news/296037186.md) - [zh-HK](https://longbridge.com/zh-HK/news/296037186.md) --- # U.S. stock night market opening fluctuations: Diginext fell 7.58% in the night market; Onfolio fell 4.63% in the night market **U.S. Stock Night Market Opening Movements** Diginext fell 7.58% in the night market. Based on recent key news: 1. On August 14, Diginex announced the signing of a revised final agreement with Resulticks, planning to create a global AI-driven group focused on customer interaction and sustainability data. This deal is valued at $1.05 billion, involving 600 million shares of Diginex stock at $1.75 per share. Resulticks' shareholders will become the major shareholders of the merged company, holding 86% of the shares. This news negatively impacted the market perception of Diginex's stock price, which fell 16.45% in pre-market trading. Source: Reuters 2. On August 14, Diginex announced it would hold a special shareholders' meeting to discuss and approve the equity purchase agreement with Resulticks and propose an increase in authorized capital. This meeting will have a direct impact on the company's future direction and structure, increasing market uncertainty. Source: Reuters 3. On August 14, Diginex announced it had secured a $70 million private financing commitment, of which at least $20 million will be injected into Diginex. This funding will support the operations and growth plans of the merged company, but the market remains cautious about the integration effects post-merger, affecting stock performance. Source: Reuters Onfolio fell 4.63% in the night market. Based on recent key news: 1. On August 14, Benzinga's Edge Stock Rankings showed that Onfolio stock exhibited a negative price trend across all time frames. This rating revealed a lack of confidence in Onfolio stock from the market, leading to a 4.63% decline in stock price during night trading. 2. Over the past 12 months, Onfolio stock has risen 113.89%, but the recent relative strength index (RSI) is only 22.85, indicating that the stock may be in an oversold state, further exacerbating market sell-off pressure. 3. Onfolio stock has traded in a range of $123.92 to $2.06 over the past 52 weeks, showing significant volatility. This instability may lead investors to worry about its future performance, thus affecting the stock price. The market is highly volatile and requires cautious observation. **Top Gainers in the U.S. Stock Night Market** Skye Bioscience rose 32.92% in the night market. Based on recent key news: 1. On August 14, Skye Bioscience announced the termination of all nimacimab research and initiated a cost-cutting plan amid competitive pressure and poor trial results. The company also plans to acquire Redx Pharma and conduct a reverse stock split to meet Nasdaq compliance requirements. This series of initiatives has attracted market attention, driving the stock price up 2. On August 14, Skye Bioscience released relevant information on the EDGAR system, disclosing the ongoing litigation and going concern risks faced by the company. This information increased market uncertainty regarding the company's future development but also attracted speculative interest from investors. 3. On August 14, Skye Bioscience mentioned in its quarterly report that the company plans to achieve a merger with Redx through transactions and financing, which is expected to bring synergies and enhance shareholder value. This prospect boosted market confidence and significantly drove up the stock price. The biotechnology industry has been quite volatile recently, and investors should exercise caution. SurgePays rose 15.78% in after-hours trading. Based on recent key news: 1. On August 14, SurgePays announced its Q2 2026 financial report, with revenue increasing by 40.7% year-on-year to $16.2 million and a net profit of $1.29 million, marking the company's return to profitability. This news drove the stock price up. 2. On August 14, the renegotiated agreement with AT&T and the progress of joint projects were viewed positively by the market, with the company expecting to maintain growth momentum in the third quarter, further boosting investor confidence. 3. On August 14, analysts rated SurgePays as "Buy," predicting a price target of $3.50 over the next 12 months, indicating significant upside potential from the current price, which enhanced market optimism for the stock. The telecommunications industry is performing strongly overall, with noticeable capital inflows. YXT.COM rose 15.41% in after-hours trading. Based on recent key news: 1. On August 14, YXT.com announced an agreement with institutional investors to acquire 500,000 ADS or prepay warrants at a price of $3 per share. This strategic financial decision aims to enhance the company's operations and potentially increase shareholder value. This move drove the stock price up. 2. On August 14, YXT.com priced a registered direct offering of 500,000 ADS, expecting total proceeds of approximately $1.5 million, planned to be completed on August 17. This news further stimulated market interest in the stock. 3. On August 14, YXT.com emphasized in a press release that its AI transformation will continue to enhance gross margins, improve operational efficiency and business outcomes, increasing investor confidence in the company's future growth. The AI industry continues to grow, with noticeable capital inflows ### Related Stocks - [DGNX.US](https://longbridge.com/en/quote/DGNX.US.md) - [ONFO.US](https://longbridge.com/en/quote/ONFO.US.md) - [SKYE.US](https://longbridge.com/en/quote/SKYE.US.md) - [SURG.US](https://longbridge.com/en/quote/SURG.US.md) - [YXT.US](https://longbridge.com/en/quote/YXT.US.md) ## Related News & Research - [Onfolio Holdings Inc. Announces Q2 2026 Financial Results and Provides Corporate Update | ONFO Stock News](https://longbridge.com/en/news/296477174.md) - [Diginex announces extraordinary shareholder meeting on Resulticks acquisition](https://longbridge.com/en/news/295927400.md) - [Onfolio Holdings Q2 revenue falls on subsidiary sales slowdown](https://longbridge.com/en/news/296476702.md) - [Diginex amends deal to buy Resulticks in US$1.05 billion all-share transaction](https://longbridge.com/en/news/295920417.md) - [Onfolio Holdings delays quarterly filing, expects Form 10-Q within five days of due date](https://longbridge.com/en/news/295970399.md)